Integral

Integral is a data privacy automation company that provides solutions for de-identifying and ensuring HIPAA compliance for sensitive healthcare data. The company's flagship product, Privacy Workbench, streamlines dataset creation by automating de-identification and compliance determination reports. The platform preserves usable data while simplifying the complex process of preparing sensitive data for merging with other datasets. The Privacy Workbench enables healthcare companies to access and analyze data while protecting personal information and respecting privacy rights. Its cloud-based platform provides visibility into risk tolerance variables and introduces statistically acceptable ranges for understanding data compliance and certification in near-real time. In October 2023, Integral launched the Privacy Simulation Suite, which allows healthcare enterprises to understand the future effects of privacy processing on datasets before completion. The suite offers proactive privacy processing that dynamically adapts to accommodate predefined preferences for variables, rows, and columns. The company's solutions integrate with various data storage systems including AWS and GCP to run uninterrupted sets of privacy assessments for quick resolution of privacy violations.

Privacy Workbench streamlines workflow management, data documentation, data privacy assessments, merging datasets, and safely storing original data. The final step includes an expert determination report with newly combined and remediated data. Through these capabilities, researchers can unlock more value from data and enhance patient care through stronger clinical trials, products, medication and health technologies.

Key customers and partnerships

In March 2024, Timothy Nobles was appointed as Chief Commercial Officer to oversee the company's sales, marketing and business development strategies. The company has established a partnership with Microsoft, receiving a grant that provides Azure server access and OpenAI technical support for AI agent development.